SCHEMBL15833570

SCHEMBL15833570

CCN(C)C(=O)Cn1ccc2cncnc21

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 18/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15833573 0.88 GRIN2B (0.44) GRIN2B
SCHEMBL15833581 0.77 NTRK1 (0.41)
SCHEMBL5068124 0.75 MKNK2 (0.42)
SCHEMBL15833685 0.73 LMNA (0.42) GRIN2B
SCHEMBL15833479 0.73 KMT2A (0.41) GRIN2B
SCHEMBL15835890 0.72 GRIN2B (0.46) GRIN2B
SCHEMBL24110604 0.72 HTR2C (0.47)
SCHEMBL15833488 0.70 MAPK13 (0.39)
SCHEMBL25299990 0.70 MKNK2 (0.36)
SCHEMBL24110586 0.70 MKNK2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014100764-A2 METHODS OF INHIBITING PRMT5 Epizyme, Inc. (US) 2014-06-26 WO disclosed
WO-2014100695-A1 PRMT5 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-06-26 WO disclosed